International Stem Cell (ISCO) Total Debt (2011 - 2020)
International Stem Cell (ISCO) posted quarterly Total Debt of $2.5 million for Q4 2020, up 4.43% year-over-year from $2.4 million in Q1 2020, and up 4.43% quarter-over-quarter from $2.4 million in Q4 2019.
International Stem Cell (ISCO) Total Debt (2011 - 2020) Analysis & Trends
International Stem Cell (ISCO) has reported Total Debt for 10 consecutive years, with $2.5 million the latest figure, recorded in Q4 2020.
- In Q4 2020, Total Debt rose 4.43% year-over-year to $2.5 million; the TTM figure through Dec 2020 stood at $2.5 million (up 4.43% YoY), while the FY2020 annual figure was $2.5 million, up 4.43% from the prior year.
- Total Debt rose to $2.5 million in Q4 2020 per ISCO's latest filing, from $2.4 million in the prior quarter.
- Across five years, Total Debt topped out at $2.8 million in Q3 2017 and bottomed at $16000.0 in Q1 2016.
- Historically, Total Debt has averaged $1.4 million across 5 years, with a median of $1.8 million in 2019.
- Annual changes were most pronounced in 2016 — Total Debt slumped 99.1% — and 2017, when it surged 10476.92%.
- International Stem Cell's Total Debt stood at $26000.0 in 2016, then soared by 10476.92% to $2.8 million in 2017, then retreated by 25.64% to $2.0 million in 2018, then gained by 15.89% to $2.4 million in 2019, then increased by 4.43% to $2.5 million in 2020.
- Business Quant data shows ISCO's Total Debt at $2.5 million in Q4 2020, $2.4 million in Q4 2019, and $1.8 million in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 546.77 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 9.34 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 770.36 Mn |
| 10 | International Stem Cell | 4.32 Mn | 3.23 Mn | 1.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 2.48 Mn |
| Dec 31, 2019 | 2.37 Mn |
| Sep 30, 2019 | 1.85 Mn |
| Jun 30, 2019 | 1.83 Mn |
| Mar 31, 2019 | 1.01 Mn |
| Dec 31, 2018 | 2.05 Mn |
| Sep 30, 2018 | 2.03 Mn |
| Jun 30, 2018 | 1.11 Mn |
| Mar 31, 2018 | 351,000.00 |
| Sep 30, 2017 | 2.75 Mn |
| Jun 30, 2017 | 2.02 Mn |
| Mar 31, 2017 | 1.31 Mn |
| Sep 30, 2016 | 26,000.00 |
| Jun 30, 2016 | 21,000.00 |
| Mar 31, 2016 | 16,000.00 |
| Dec 31, 2015 | 3.13 Mn |
| Sep 30, 2015 | 2.89 Mn |
| Jun 30, 2015 | 2.29 Mn |
| Mar 31, 2015 | 16,000.00 |
| Dec 31, 2014 | 11,000.00 |